1 in 3 patients
experience bleeding-related complications during surgery that impact recovery1

Surgical teams
can improve their preparation for and response to intraoperative bleeding events by enhancing their communication

What would your active hemostasis strategy be for your patient?

 

Patient Profiles are changing; increasing the risk of bleeding complications2

At least 62% of adults aged 65-74 have multiple comorbidities2

 
 
81.5%
62%

Prevalence of
multiple comorbidities increases to >80% in adults aged ≥852

Many patients have comorbidities or use medications that can compromise their coagulation status

15%

of US adults have chronic kidney disease3

Incidence increasing with age 44% of adults 70 and older3

30%

of the US population use low-dose aspirin for CVD prevention4

~ 2/3

of surgical patients are treated with anticoagulants and/or antiplatelets* 5

*Based on Premier Database data

1 in 50

adults have liver disease6

1 in 3

adults will be diagnosed with cancer in their lifetime7

A compromised coagulation status increases the risk of intraoperative bleeding complications8

Watch how hemostasis is achieved when the patient’s coagulation is intact

Watch Video

But what happens if the patient’s coagulation status is compromised?

Watch Video
 
 

Active adjunctive hemostats are more effective than passive hemostats9-11

  • Function independently of the patient’s ability to generate clotting factors to achieve hemostasis
  • Effective regardless of coagulation status
  • Effective across a wide range of bleeding

Two categories of adjunct hemostats

Hover over each category to view adjunct hemostats

Tap each category to view adjunct hemostats

 
 

Active adjunctive hemostats are more effective than passive hemostats9-11

  • Function independently of the patient’s ability to generate clotting factors to achieve hemostasis
  • Effective regardless of coagulation status
  • Effective across a wide range of bleeding

Two categories of adjunct hemostats

Tap each category to view adjunct hemostats

 
 

A common language – Validated intraoperative bleeding Scale (VIBE) facilitates team communication & response to intraoperative bleeding12

 
 

Learn more about the first surgeon validated and FDA accepted intraoperative bleeding scale. Click here.

 

The VIBe SCALE is the first surgeon-validated scale for assessment of intraoperative bleeding severity.12

By utilizing VIBe, surgical teams can better choose the right product for the right bleed and differentiate the efficacy of active vs passive hemostats.13

Active hemostats are able to control a wide range of bleeding from Grade 1 to Grade 3.13

Click each grade of bleed to see an example.

Tap each grade of bleed to see an example.

 
Click to see Grade 0 No Bleed Click to see Grade 1 Intermittent Flow Click to see Grade 2 Continuous Flow Click to see Grade 3 Controllable Spurting Overwhelming Flow Click to see Grade 4 Unidentified / Inaccessible Spurting or Gush
Click to see Grade 0 No Bleed Click to see Grade 1 Intermittent Flow Click to see Grade 2 Continuous Flow Click to see Grade 3 Controllable Spurting Overwhelming Flow Click to see Grade 4 Unidentified / Inaccessible Spurting or Gush
 

*As demonstrated in preclinical studies only.

Surgical teams can efficiently respond to intraoperative bleeding by proactively assessing a patient’s coagulation status and implementing the VIBe SCALE- reducing bleeding complications and improving surgical efficiency.12,14

Find out how your team can choose the right product for the right bleed.

Contact Us

References

1. Stokes ME, et al. BMC Health Services Research 2011;11:135; 2. Salive ME. Epidemiol Rev 2013;35:75–83; 3. https://nccd.cdc.gov/CKD/AreYouAware.aspx?emailDate=September_2020#refreshPosition; 4. Stuntz M, et al. Prev Med Rep. 2017;5:183–186; 5. Data on File – Preliminary Results, Summary of Premier Data, 2018Q1 to 2019Q2; 6. Centers for Disease Control and Prevention. Chronic Liver Disease and Cirrhosis. Available at: https://www.cdc.gov/nchs/fastats/liver-disease.htm (Accessed January 2020); 7. American Cancer Society. Facts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years, Jan 2019. Available at: https://www.cancer.org/latest-news/facts-and-figures-2019.html (Accessed January 2020); 8. Corral M, et al. Clinicoecon Outcomes Res 2015;7:409–21; 9. Slezak P, et al. J Invest Surg 2020; Jan 20; 1-7. doi: 10.1080/08941939.2019.1705444; 10. Nasso G, et al. Ann Thorac Surg 2009;88:1520–6; 11. Bracey A, et al. Ann Thorac Surg 2017;104:353–60; 12. Lewis KM, Li Q, Jones DS, et al. Surgery. 2017; 161:771–781.; 13. Baxter Data on File BWQ026-IS17/BWQ027-IS17; 14. Leval, M. Journal of Thoracic and Cardiovascular Surg. 2000; 119:661-672

Back
to top